Recognition of biomarker identified high-risk patients in the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban study resulting in a protocol amendment

Cohen Alexander T.; Harrington Robert; Goldhaber Samuel Z.; Hull Russell; Gibson C. M.; Hernandez Adrian F.; Gold Alex

首页> 外文期刊>The American heart journal >Recognition of biomarker identified high-risk patients in the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban study resulting in a protocol amendment

【24h】

Recognition of biomarker identified high-risk patients in the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban study resulting in a protocol amendment

机译：在延长治疗期限的Betrixaban研究中，对急性医学疾病静脉血栓栓塞预防的生物标志物识别高危患者的识别，从而导致方案修订

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The American heart journal》 |2015年第1期|共2页
作者
Cohen Alexander T.; Harrington Robert; Goldhaber Samuel Z.; Hull Russell; Gibson C. M.; Hernandez Adrian F.; Gold Alex;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Recognition of biomarker identified high-risk patients in the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban study resulting in a protocol amendment [J] . Cohen Alexander T., Harrington Robert, Goldhaber Samuel Z., The American heart journal . 2015,第1期

机译：在延长治疗期限的Betrixaban研究中，对急性医学疾病静脉血栓栓塞预防的生物标志物识别高危患者的识别，从而导致方案修订
2. The design and rationale for the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban (APEX) study [J] . CohenA.T., HarringtonR., GoldhaberS.Z., The American heart journal . 2014,第3期

机译：延长持续时间贝曲西班（APEX）研究预防急性医学疾病静脉血栓栓塞的设计和原理
3. Betrixaban for first-line venous thromboembolism prevention in acute medically ill patients with risk factors for venous thromboembolism [J] . Tarek Nafee, C. Michael Gibson, Megan K. Yee, Expert review of cardiovascular therapy . 2018,第7a12期

机译：Betrixaban在急性医疗患者患静脉血栓栓塞患者中预防急性静脉血栓栓塞患者
4. Can More High-Risk Cardiovascular Patients be Identified Using Novel Biomarkers? Extending the msm Package to Measure Reclassification [C] . Felicity Lamrock, Karen Cairns, Annette Conrads-Frank, IEEE International Symposium on Computer-Based Medical Systems . 2016

机译：可以使用新型生物标志物识别更多高危心血管患者吗？扩展msm包以衡量重新分类
5. Betrixaban for prevention of venous thromboembolism in acute medically ill patients [O] . Jan Beyer-Westendorf, Peter Verhamme, Rupert Bauersachs -1

机译：贝曲西班预防急性病患者的静脉血栓栓塞
6. Effectiveness and safety of betrixaban extended prophylaxis for venous thromboembolism compared with standard-duration prophylaxis intervention in acute medically ill patients: a systematic literature review and network meta-analysis [O] . Vicki Laskier, Holly Guy, Mark Fisher, 2019

机译：与急性医疗病患者的标准持续时间预防患者的静脉血栓栓塞对静脉血栓栓塞的延长预防的有效性和安全性：系统文献综述和网络元分析

Recognition of biomarker identified high-risk patients in the Acute Medically Ill Venous Thromboembolism Prevention with Extended Duration Betrixaban study resulting in a protocol amendment

著录项

相似文献

相关主题

期刊订阅